Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-05 · accession 0001593968-24-000838 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-07 | 2024-06-05 | ALLO | Humer Franz B | Dir | A - Grant | $0.00 | +61.5K | 316.7K | +24% | $0 |
| D | 2024-06-07 | 2024-06-05 | ALLO | Humer Franz B | Dir | A - Grant | $0.00 | +95.5K | 95.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-05 | A | A | 61,475 | $0.00 | 316,728 | D | — | — | |
| 2 | Derivative | Stock Option (Right to buy) | 2024-06-05 | A | A | 95,541 | $0.00 | 95,541 | D | $2.44 · — to 2034-06-05 | 95,541 Common Stock | (F1) Vesting in 12 equal monthly installments |